Cargando…
Silencing of Abcc8 or inhibition of newly upregulated Sur1-Trpm4 reduce inflammation and disease progression in experimental autoimmune encephalomyelitis
BACKGROUND: In experimental autoimmune encephalomyelitis (EAE), deletion of transient receptor potential melastatin 4 (Trpm4) and administration of glibenclamide were found to ameliorate disease progression, prompting speculation that glibenclamide acts by directly inhibiting Trpm4. We hypothesized...
Autores principales: | Makar, Tapas K., Gerzanich, Volodymyr, Nimmagadda, Vamshi K.C., Jain, Rupal, Lam, Kristal, Mubariz, Fahad, Trisler, David, Ivanova, Svetlana, Woo, Seung Kyoon, Kwon, Min Seong, Bryan, Joseph, Bever, Christopher T., Simard, J. Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652344/ https://www.ncbi.nlm.nih.gov/pubmed/26581714 http://dx.doi.org/10.1186/s12974-015-0432-3 |
Ejemplares similares
-
Immunomodulatory therapy with glatiramer acetate reduces endoplasmic reticulum stress and mitochondrial dysfunction in experimental autoimmune encephalomyelitis
por: Makar, Tapas K., et al.
Publicado: (2023) -
Salutary effects of glibenclamide during the chronic phase of murine experimental autoimmune encephalomyelitis
por: Gerzanich, Volodymyr, et al.
Publicado: (2017) -
HIV-1 Vpr-Induced Proinflammatory Response and Apoptosis Are Mediated through the Sur1-Trpm4 Channel in Astrocytes
por: Li, Ge, et al.
Publicado: (2020) -
The Sulfonylurea Receptor 1 (Sur1)-Transient Receptor Potential Melastatin 4 (Trpm4) Channel
por: Woo, Seung Kyoon, et al.
Publicado: (2013) -
SUR1-TRPM4 channel activation and phasic secretion of MMP-9 induced by tPA in brain endothelial cells
por: Gerzanich, Volodymyr, et al.
Publicado: (2018)